9/1/2021CDE Solicits Comments on the Technical Guidance on Clinical Protocol f...

9/1/2021Junshi Bio and Coherus Completes Rolling BLA Submission of Toripalimab...

9/1/2021CStone Files Chinese NDA of Sugemalimab for Stage III NSCLC

9/1/2021U.S. FDA Apprves BeiGene's BRUKINSA (Zanubrutinib) for Waldenström's ...

9/1/2021Harbour BioMed Gets Chinese IND Approval for PII Trial of Anti-FcRn Ba...

8/31/2021Insilico and 4B Tech Tie Up to Advance Drug Discovery for Neurodegener...

8/31/2021NHSA Issues the Notice on the Public Service Item List of Centralized ...

8/31/2021Financial-related Company News in Brief (August 2021)

8/31/2021Eight Central Government Agencies Issues the Pilot Plan for Deepening ...

8/31/2021Jingxin In-licenses Epilepsy Drug from Bio-Pharm Solutions for $40M

8/31/2021HUYABIO Files an IND with the FDA for the Novel SHP2 Inhibitor HBI-237...

8/31/2021InnoCare Pharma to Launch US Trial of ICP-723 for NTRK Fusion-Positive...

8/30/2021NMPA Issues the Notice on Deepening Certification and Licensing Separa...

8/30/2021CDE Solicits Comments on the Technical Guidance on Clinical Pharmacolo...

8/30/2021Ligand's Partner Gloria Bio Wins Chinese Approval for Zimberelimab

8/30/2021Judges Send GSK Corporate Drama to Court in Philadelphia

8/30/2021China Misses Target on Approval of Biontech-Pfizer Shot, Raising Quest...

8/30/2021Winners and Losers in China's Sweeping Private-Sector Crackdown

8/29/2021NHSA Concludes the List of Drugs Passing Form Evaluation for Inclusion...

8/29/2021CDE Solicits Comments on the Technical Guidance for Non-Clinical Drug ...

8/29/2021CDE Solicits Comments on the Procedures and Requirements for Filing Po...

8/27/2021Junshi Bio Granted Chinese IND Approval for Subcutaneous Injection of ...

8/27/2021Lynk Pharma Completes $50M Series B Financing

8/27/2021Innovent and Bolt Bio Collaborate for Three New Oncology Boltbody ISAC...

8/27/2021Laekna Receives IND Approvals in China and US for Phase Ib/III Global ...

8/27/2021CDE Issues Three Guidance Documents on Non-clinical Research of Nanome...

8/27/2021NMPA Withdraws Approvals of 46 Domestic and Foreign Drug Products

8/27/2021Recent Executive Moves

8/27/2021Chinese Patent Linkage, Patent Term Adjustment, and Patent Term Extens...

8/26/2021BeyondSpring Announces Exclusive Deal with Jiangsu Hengrui Pharma for ...

Page:116/719 Total number of articles:21549: [First][<<] [114] [115] [116] [117] [118] [>>] [End]